Hualan Biological Engineering, Inc. News

Hualan Biotech (002007): The company announced plans to increase its holdings and the blood products business is developing steadily

Jul 9 00:00

Hualan Biotech (002007): Actual controllers and executives plan to increase their holdings in the company to highlight long-term development potential

Jul 9 00:00

Hualan Biology (002007): Blood products business is steady awaiting the release of influenza vaccine

May 8 00:00

Hualan Biology (002007): The Q1 blood products business remains steady and we expect the influenza vaccine to be released

May 2 00:00

Hualan Biotech (002007): 1Q24 revenue was affected by seasonal fluctuations in vaccine, and the growth of blood products was relatively stable

Apr 29 07:56

Hualan Biology (002007): Stable blood products and vaccines return to normal

Apr 27 00:00

China Post Securities released a research report on April 26 stating that Hualan Biotech (002007.SZ) was given a purchase rating. The main reasons for the rating include: 1) The growth rate of blood products slowed down during the same period last year; 2

Zhitong FinanceApr 26 18:02

Hualan Biology (002007): The growth rate of pulp collection is impressive, and the blood products business is expected to accelerate

Apr 16 21:01

Hualan Biology (002007): Continued increase in the company's pulp collection is expected to drive the accelerated growth of the blood products business

Apr 10 00:00

Hualan Biotech (002007): Performance is in line with expectations, accelerated pulp collection lays the foundation for future growth

Apr 8 00:00

Hualan Biotech (002007): Performance is in line with expectations, slurry volume growth exceeds expectations

Apr 5 00:00

Hualan Biology (002007) Company Brief Review Report: Increased pulp collection volume can be expected to increase significantly

Apr 3 18:06

Hualan Biotech (002007): Blood products+vaccine dual-wheel drive will positively return shareholders in the next three years

Apr 3 14:16

Hualan Biotech (002007): Profitability of blood products enhances vaccine contribution performance flexibility

Apr 2 11:46

Hualan Biology (002007) 2023 Annual Report Review: Increased pulp collection and gradual increase in the competitiveness of vaccine companies

Apr 1 14:51

Hualan Biotech (002007): Profits slightly exceeded expectations, blood product plasma collection expanded rapidly

Apr 1 13:41

Hualan Biology (002007): Rapid increase in pulp collection and recovery of high vaccine growth

Apr 1 00:00

Hualan Biotech (002007): Performance is in line with expectations, pulp harvesting has entered a new growth cycle

Apr 1 00:00

Hualan Biology (002007): Blood products business is growing steadily, and influenza vaccine is being released rapidly

Mar 30 00:00

Hualan Biotech (002007): Performance is in line with expectations and strengthens shareholder returns

Mar 29 00:00